Nevro Corp

Medical Devices

Prices are adjusted according to historical splits.

Nevro Corp Stock Price


Today's Low:
Today's High:
Open Price:
52W Low:
52W High:
Prev. Close:

Company Statistics

Market Cap.:
$728.18 million
Book Value:
Revenue TTM:
$419.45 million
Operating Margin TTM:
Gross Profit TTM:
$276.37 million
Profit Margin:
Return on Assets TTM:
Return on Equity TTM:

Company Profile

Nevro Corp had its IPO on 2014-11-06 under the ticker symbol NVRO.

The company operates in the Healthcare sector and Medical Devices industry. Nevro Corp has a staff strength of 1,087 employees.

Stock update

Shares of Nevro Corp opened at $19.91 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $19.56 - $20.3, and closed at $20.28.

This is a +0.6% increase from the previous day's closing price.

A total volume of 444,848 shares were traded at the close of the day’s session.

In the last one week, shares of Nevro Corp have slipped by -0.54%.

Nevro Corp's Key Ratios

Nevro Corp has a market cap of $728.18 million, indicating a price to book ratio of 4.5054 and a price to sales ratio of 3.5244.

In the last 12-months Nevro Corp’s revenue was $419.45 million with a gross profit of $276.37 million and an EBITDA of $-97902000. The EBITDA ratio measures Nevro Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Nevro Corp’s operating margin was -24.85% while its return on assets stood at -11.92% with a return of equity of 0.98%.

In Q2, Nevro Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 4.4%.

Nevro Corp’s PE and PEG Ratio

Forward PE
Trailing PE

Its diluted EPS in the last 12-months stands at $0.1 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of -3.13. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Nevro Corp’s profitability.

Nevro Corp stock is trading at a EV to sales ratio of 3.2262 and a EV to EBITDA ratio of 109.3985. Its price to sales ratio in the trailing 12-months stood at 3.5244.

Nevro Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$569.52 million
Total Liabilities
$77.53 million
Operating Cash Flow
Capital Expenditure
$2.21 million
Dividend Payout Ratio

Nevro Corp ended 2024 with $569.52 million in total assets and $0 in total liabilities. Its intangible assets were valued at $569.52 million while shareholder equity stood at $294.75 million.

Nevro Corp ended 2024 with $0 in deferred long-term liabilities, $77.53 million in other current liabilities, 36000.00 in common stock, $-666950000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $65.19 million and cash and short-term investments were $329.94 million. The company’s total short-term debt was $0 while long-term debt stood at $187.49 million.

Nevro Corp’s total current assets stands at $531.35 million while long-term investments were $0 and short-term investments were $264.76 million. Its net receivables were $69.40 million compared to accounts payable of $30.30 million and inventory worth $120.09 million.

In 2024, Nevro Corp's operating cash flow was $0 while its capital expenditure stood at $2.21 million.

Comparatively, Nevro Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
52-Week High
52-Week Low
Analyst Target Price

Nevro Corp stock is currently trading at $20.28 per share. It touched a 52-week high of $50.54 and a 52-week low of $50.54. Analysts tracking the stock have a 12-month average target price of $28.33.

Its 50-day moving average was $21.75 and 200-day moving average was $30.73 The short ratio stood at 3.25 indicating a short percent outstanding of 0%.

Around 281.5% of the company’s stock are held by insiders while 10292.9% are held by institutions.

Frequently Asked Questions About Nevro Corp

The stock symbol (also called stock or share ticker) of Nevro Corp is NVRO

The IPO of Nevro Corp took place on 2014-11-06

Similar Industry Stocks (Medical Devices)

Last Price
Vedant Asset Ltd (VEDANTASSET)

Most Active

Last Price
Amyris Inc (AMRS)
Humbl Inc (HMBL)

Top Gainers

Last Price
Latch Inc (LTCHW)

Top Losers

Last Price


Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation system for the treatment of chronic pain, as well as Senza II and Senza Omnia SCS systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company’s Senza HFX iQ IPG system includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system. In addition, it offers surpass surgical and percutaneous leads. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.


1800 Bridge Parkway, Redwood City, CA, United States, 94065